Cours Lonza Group Ltd Other OTC
Actions
LZAGY
US54338V1017
Recherche biotechnologique et médicale
CA 2024 * | 6,66 Md 7,33 Md | CA 2025 * | 7,55 Md 8,31 Md | Capitalisation | 37,24 Md 40,98 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 887 M 976 M | Résultat net 2025 * | 1,09 Md 1,2 Md | VE / CA 2024 * | 6 x |
Dette nette 2024 * | 2,71 Md 2,98 Md | Dette nette 2025 * | 3,17 Md 3,49 Md | VE / CA 2025 * | 5,35 x |
PER 2024 * |
41,9
x | PER 2025 * |
33,7
x | Employés | - |
Rendement 2024 * |
0,87% | Rendement 2025 * |
1% | Flottant | 95,87% |
Dernier transcript sur Lonza Group Ltd
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/04/17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/12/21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/08/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/04/14 |
Director/Board Member | 66 | 16/04/14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/05/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,37% | 44,96 Md | |
-1,01% | 42,65 Md | |
-5,31% | 29,04 Md | |
+9,34% | 26,08 Md | |
-21,69% | 19,03 Md | |
+6,23% | 12,75 Md | |
+26,99% | 12,06 Md | |
-3,38% | 11,75 Md | |
+20,21% | 11,72 Md |